Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $7.22B | $7.45B | -3.06% |
Cost of Revenue | $1.73B | $1.92B | -9.83% |
Net Income | $1.37B | $911.4M | +49.82% |
EPS (Basic) | $9.38 | $6.30 | +48.89% |
EPS (Diluted) | $9.35 | $6.26 | +49.36% |
SG&A Expense | $1.72B | $1.94B | -11.20% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $28.31B | $28.19B | +0.43% |
Current Assets | $6.83B | $8.45B | -19.20% |
Total Liabilities | $11.95B | $13.71B | -12.83% |
Current Liabilities | $5.42B | $5.02B | +8.02% |
Long-Term Debt | $4.55B | $6.79B | -33.02% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $2.11B | $1.53B | +37.79% |
Investing Cash Flow | $-780.6M | $-3.45B | +77.37% |
Financing Cash Flow | $-691.4M | $795.4M | -186.92% |
D&A | $489.2M | $354.7M | +37.92% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Net Margin | 18.9% | — | — |
ROA | 4.8% | — | — |
Current Ratio | $1.259 | — | — |
Other companies in Biotechnology